Tag: GW

October 19, 2016 Off

GW Pharmaceutical cancels trading shares on AIM on December 2, 1016, continues trading on NASDAQ

GW Pharmaceuticals plc has announced leaving AIM and canceling trading in London, to continue trading only on NASDAQ.

October 27, 2015 Off

GW Pharmaceuticals signs MOU to research Epudiolex with New South Wales (Australia)

GW Pharmaceuticals plc, has signed a Memorandum of Understanding (MOU) with the Government of New South Wales (NSW) in Australia to progress a research program for Epidiolex (cannabidiol or CBD) and cannabidivarin (CBDV) in children with severe, drug resistant childhood epilepsy.